In the era of precision medicine there are competing demands placed on the use of tissue such as routine pathology diagnostics or biomarker studies to determine patient clinical trial eligibility or treatments.
In the American Journal of Clinical Pathology published on Oct. 15, health care partner Mark Barnes (Boston) and co-authors examined the barriers and strategic solutions to advance diagnostic tissue submission for clinical trials. Following a National Cancer Institute workshop, the authors propose recommendations to reduce institutional barriers and assist organizations in developing policies on diagnostic tissue block submission for clinical trials.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.